Lightcalls.com
 

Too frequently organizations don't ...

Too frequently organizations don't realize they're vulnerable to fraud and other misconduct until they become the victims of them. And chiefly often, the person behind the deception is a trusted employee a valued business partner or vendor, or equable a member of the management team. The damage to an organization from potential fraudulent activity can be immeasurable, the penalties morose and the costs high. Corporate victims may sustain public embarrassment, lose customers, be prohibited from bidding forward new business, and incur punishing financial losse

Defining fraud and misconduct

For the purports of this article, "fraud and misconduct" commit to all of those activities involving dishonesty and deception that can drain value from a business, directly or indirectly-whether or not there is a personal benefit to the perpetrator.

Although this definition involves more [i]or[/i] less of the elements required to examine fraud in a court of law (dishonesty and deception) it encompasses a earnestly broader range of activities than are traditionally prosecut in court. It includes, for example, gros mismanagement involving deception, unauthorized risk-taking, irregularities, manipulation, and theft.



It can happen here

Have the originals of financial disaster already been planted in a Canadian companies? Could fraud and misconduct be draining

CONVERSTORY

Surely after the catastrophic failures of Enron WorldCom, and other late headline-grabbing financial shenanigans, the business world has learned an important rebuke But how many Canadian companies (and their auditors) still think it could not at all happen to them?

It's surprising for what cause many companies continue to suppres the "fraud" word because it doesn't fit with their tillages of "trust" and 11 empowerment." Historically, many boards of directors, audit committees, CEO CFO and heads of internal audit in Canada have probably considered their organizations' susceptibility to fraud and misconduct to be subdued perhaps indicating a widespread, notwithstanding unspoken, assumption that everyone is fair In the "post-Enron environment," it's clearly an assumption that straits questioning.

Many of these same clumps are now asking what they can do to interrupt their companies from providing tomorrow's scandalous headlines for the financial pres further negative press aside, there are other equally compelling reasons with what intent they-and you-should be concerned about fraud and misconduct.

Consider the following external hurrys for tighter corporate governance and risk management:

Regulatory pronouncements, of the like kind as the corporate governance guidelines of the Toronto Stock Exchange, which state that the board of directors should assume responsibility for the identification of the principal risks of the corporations business, and the implementation of appropriate connected views to manage those risks. In considering the principal risks, directors should not look down upon fraud risks.

The requirement for CEO and CFO of SEC registrants to certify reports containing financial statements, beneath the recently approved US legislation commonly known as the Sarbanes-Oxley Act. These officers will without doubt want some assurance that an effective fraud risk management program is in place before providing like certifications.

The requirements of the revised S5135 of the CICA Accounting Handbook regarding the auditor's responsibility to consider fraud and error in the audit of financial statements. Auditors are required to make enquiries of management regarding fraud risk and to discuss the matter with the audit committee, thereby placing increased constraining force on management and audit committees to address risks pos by the agency of fraud.

Increased public awareness of fraud and misconduct in the post-Enron environment, which will further increase the risk of litigation against directors, officers, and auditors.

Learning from modern events

As the facts and circumstances underlying the modern financial disasters begin to come up it's clear that the following contributory factors were present:

Pressure

Pressure is frequently a major cause of fraud.

What hurrys are people under in your company? Business presss such as meeting financial reporting targets, incentive plans tied closely to financial conclusions and the desire for promotion. And there are ofttimes personal pressures-gambling habits, substance abuse riddles divorce settlements, debt, and extravagant lifestyles.

If you fail to recognize and manage of that kind pressures, don't be surprised when fraud is subsequently lay bareed

Escalation

Escalation usually conclusions from a lack of attention to small-scale infractions. The majority of frauds begin with a small error, which is then concealed, or unauthorized risk-taking of a minor nature. Effective fraud risk management should seek for to detect these minor incidents before they spiral abroad of control into a major fraud.

Fraud awareness at all flats of the organization, clear reporting channels, and protection for those who report suspicions of fraud, will proceed a long way to ensuring detection at an early stage. Better still, rigorous recruitment screening should render certain you don't hire "bad apples" in the first place.



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.